And that’s only the beginning.
2月24日晚，长春高新（000661.SZ）子公司金赛药业宣布，自主研发的GenSci141软膏的临床试验申请已获得国家药监局批准。根据此前公告，GenSci141软膏是金赛药业研发的一款双氢睾酮软膏，主要以旁分泌的方式在靶组织内发挥作用，属于化学药品2.2和2.4类。该药物可用于改善因高促性腺激素性性腺功能减退症、5α-还原酶2缺乏症、雄激素合成减少的先天性肾上腺皮质增生症、特发性原因导致的儿童小阴茎。截至目前，全球尚无一款专门针对儿童小阴茎的药物，因此该软膏备受市场关注。
，推荐阅读旺商聊官方下载获取更多信息
security add-generic-password -a "$USER" -s "secure-env-demo/api-key" -w "sk-your-key" -U
By WWII, scientists had already begun looking at alternative gelling substances for routine use in bacteriology, but concluded that agar was still better as it is both firmer and easier to handle. Today, some specialized microbiology applications use the colloid carrageenan (extracted from red seaweed Chondrus crispus, or “Irish Moss”), a more transparent and less auto-fluorescent alternative to agar (agar emits its own background fluorescence when excited by light). However, for routine bacteriological use, carrageenan is more difficult to dissolve, requires higher concentrations, can degrade at high temperatures, and forms weaker gels, which may result in puncturing its surface during the plating of cells.